Although elevated YAP expression and its nuclear accumulation are known to be associated with poor disease-specific survival in gastric cancer patients [12], the precise molecular mechanisms underlying the regulatory effects of YAP in gastric carcinogenesis remain poorly understood. This evidence concerns the gene YAP1 and gastric cancer.